Tocqueville Asset Management’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-55,350
Closed -$545K 822
2017
Q1
$545K Sell
55,350
-730,625
-93% -$8.84M 0.01% 571
2016
Q4
$8.57M Sell
785,975
-388,755
-33% -$4.08M 0.11% 212
2016
Q3
$16.5M Sell
1,174,730
-225,913
-16% -$1.84M 0.2% 135
2016
Q2
$9.83M Sell
1,400,643
-87,355
-6% -$641K 0.12% 197
2016
Q1
$9.58M Buy
1,487,998
+516,205
+53% +$8.96M 0.13% 184
2015
Q4
$31.5M Buy
971,793
+216,065
+29% +$6.36M 0.43% 63
2015
Q3
$20.2M Buy
755,728
+178,350
+31% +$7.63M 0.27% 118
2015
Q2
$27.8M Buy
577,378
+5,955
+1% +$347K 0.33% 93
2015
Q1
$34.8M Sell
571,423
-31,885
-5% -$1.95M 0.41% 74
2014
Q4
$31.2M Buy
603,308
+32,008
+6% +$1.41M 0.34% 98
2014
Q3
$25.1M Buy
571,300
+299,487
+110% +$9.37M 0.28% 120
2014
Q2
$7.11M Buy
271,813
+197,313
+265% +$4.22M 0.07% 261
2014
Q1
$1.95M Buy
74,500
+9,450
+15% +$254K 0.03% 383
2013
Q4
$1.1M Buy
65,050
+16,200
+33% +$285K 0.01% 434
2013
Q3
$1.05M Buy
+48,850
New +$849K 0.01% 505

Other funds holding PTCT